Page last updated: 2024-10-18

dalteparin and Lymphoma

dalteparin has been researched along with Lymphoma in 2 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, B1
Chan, S1
Servaes, S1
Zhuang, H1
Izzedine, H1
Cluzel, P1
Deray, G1

Other Studies

2 other studies available for dalteparin and Lymphoma

ArticleYear
Multiple FDG-avid injection site granulomas due to lovenox injection.
    Clinical nuclear medicine, 2014, Volume: 39, Issue:3

    Topics: Adolescent; Enoxaparin; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Injections; Lymphoma; Mul

2014
Renal radiation-induced arterial stenosis.
    Kidney international, 2007, Volume: 71, Issue:11

    Topics: Adult; Angioplasty, Balloon; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Hodgkin Disease; Hu

2007